SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Nuveen California Select Tax-Free Income Portfolio (NXC) trades at a trailing P/E of 38.0. Trailing earnings yield is 2.63%.
Criteria proven by this page:
- VALUE (40/100, Partial) — mixed signals — some valuation metrics are favorable while others are stretched.
- Trailing Earnings Yield 2.63% — below bond yields — investors are paying a premium for expected growth rather than current earnings.
Overall SharesGrow Score: 57/100 with 2/7 criteria passed.
SharesGrow 7-Criteria Score
~
VALUE
40/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — NXC
Valuation Multiples
P/E (TTM)38.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio23.01
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.35
Book Value / Share$0.00
Revenue / Share$0.58
FCF / Share$0.00
Yields & Fair Value
Earnings Yield2.63%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2015 |
$0.83 |
$4.52M |
$5.21M |
115.2% |
| 2016 |
$0.04 |
$4.03M |
$231.34K |
5.7% |
| 2017 |
$0.66 |
$4.3M |
$4.19M |
97.5% |
| 2018 |
$0.69 |
$4.66M |
$4.39M |
94.2% |
| 2019 |
$0.74 |
$4.8M |
$4.7M |
97.9% |
| 2020 |
$0.92 |
$5.95M |
$5.85M |
98.4% |
| 2021 |
$0.00 |
$3.5M |
$-1.39M |
-39.7% |
| 2022 |
$-0.94 |
$-5.9M |
$-5.99M |
- |
| 2023 |
$0.80 |
$5.19M |
$5.1M |
98.3% |
| 2024 |
$0.35 |
$3.7M |
$2.25M |
60.7% |
